Literature DB >> 16968849

Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome.

Jenny B Hobbs1, Derick R Peterson, Arthur J Moss, Scott McNitt, Wojciech Zareba, Ilan Goldenberg, Ming Qi, Jennifer L Robinson, Andrew J Sauer, Michael J Ackerman, Jesaia Benhorin, Elizabeth S Kaufman, Emanuela H Locati, Carlo Napolitano, Silvia G Priori, Jeffrey A Towbin, G Michael Vincent, Li Zhang.   

Abstract

CONTEXT: Analysis of predictors of cardiac events in hereditary long-QT syndrome (LQTS) has primarily considered syncope as the predominant end point. Risk factors specific for aborted cardiac arrest and sudden cardiac death have not been investigated.
OBJECTIVE: To identify risk factors associated with aborted cardiac arrest and sudden cardiac death during adolescence in patients with clinically suspected LQTS. DESIGN, SETTING, AND PARTICIPANTS: The study involved 2772 participants from the International Long QT Syndrome Registry who were alive at age 10 years and were followed up during adolescence until age 20 years. The registry enrollment began in 1979 at 5 cardiology centers in the United States and Europe. MAIN OUTCOME MEASURES: Aborted cardiac arrest or LQTS-related sudden cardiac death; follow-up ended on February 15, 2005.
RESULTS: There were 81 patients who experienced aborted cardiac arrest and 45 who had sudden cardiac death; 9 of the 81 patients who had an aborted cardiac arrest event experienced subsequent sudden cardiac death. Significant independent predictors of aborted cardiac arrest or sudden cardiac death during adolescence included recent syncope, QTc interval, and sex. Compared with those with no syncopal events in the last 10 years, patients with 1 or 2 or more episodes of syncope 2 to 10 years ago (but none in the last 2 years) had an adjusted hazard ratio (HR) of 2.7; (95% confidence interval [CI], 1.3-5.7; P<.01) and an adjusted HR of 5.8 (95% CI, 3.6-9.4; P<.001), respectively, for life-threatening events; those with 1 syncopal episodes in the last 2 years had an adjusted HR of 11.7 (95% CI, 7.0-19.5; P<.001) and those with 2 or more syncopal episodes in the last 2 years had an adjusted HR of 18.1 (95% CI, 10.4-31.2; P<.001). Irrespective of events occurring more than 2 years ago, QTc of 530 ms or longer was associated with increased risk (adjusted HR, 2.3; 95% CI, 1.6-3.3; P<.001) compared with those having a shorter QTc. Males between the ages of 10 and 12 years had higher risk than females (HR, 4.0; 95% CI, 1.8-9.2; P = .001), but there was no significant risk difference between males and females between the ages of 13 and 20 years. Among individuals with syncope in the past 2 years, beta-blocker therapy was associated with a 64% reduced risk (HR, 0.36; 95% CI, 0.18-0.72; P<.01).
CONCLUSIONS: In LQTS, the timing and frequency of syncope, QTc prolongation, and sex were predictive of risk for aborted cardiac arrest and sudden cardiac death during adolescence. Among patients with recent syncope, beta-blocker treatment was associated with reduced risk.

Entities:  

Mesh:

Year:  2006        PMID: 16968849     DOI: 10.1001/jama.296.10.1249

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  65 in total

1.  Economic evaluation of strategies to reduce sudden cardiac death in young athletes.

Authors:  Michael Schoenbaum; Peter Denchev; Benedetto Vitiello; Jonathan R Kaltman
Journal:  Pediatrics       Date:  2012-07-02       Impact factor: 7.124

2.  Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1.

Authors:  Martin H Ruwald; Xiaorong Xu Parks; Arthur J Moss; Wojciech Zareba; Jayson Baman; Scott McNitt; Jorgen K Kanters; Wataru Shimizu; Arthur A Wilde; Christian Jons; Coeli M Lopes
Journal:  Heart Rhythm       Date:  2015-08-28       Impact factor: 6.343

3.  Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals.

Authors:  Ilan Goldenberg; Samuel Horr; Arthur J Moss; Coeli M Lopes; Alon Barsheshet; Scott McNitt; Wojciech Zareba; Mark L Andrews; Jennifer L Robinson; Emanuela H Locati; Michael J Ackerman; Jesaia Benhorin; Elizabeth S Kaufman; Carlo Napolitano; Pyotr G Platonov; Silvia G Priori; Ming Qi; Peter J Schwartz; Wataru Shimizu; Jeffrey A Towbin; G Michael Vincent; Arthur A M Wilde; Li Zhang
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

4.  Sudden arrhythmic death syndrome.

Authors:  Bruce A Koplan; William G Stevenson
Journal:  Heart       Date:  2007-05       Impact factor: 5.994

Review 5.  The risk of cardiac events and genotype-based management of LQTS patients.

Authors:  Grazyna Markiewicz-Łoskot; Ewa Moric-Janiszewska; Urszula Mazurek
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

6.  Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death.

Authors:  Brett R Anderson; Sean McElligott; Daniel Polsky; Victoria L Vetter
Journal:  Pediatr Cardiol       Date:  2013-09-05       Impact factor: 1.655

7.  Near death and neurocardiogenic syncope.

Authors:  Teresa Donnelly; Sheila Carew; Tina Sheehy; Aine Costelloe; Gerard Fahey; Declan Lyons
Journal:  Clin Auton Res       Date:  2007-08-23       Impact factor: 4.435

8.  Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.

Authors:  Arthur J Moss; Wataru Shimizu; Arthur A M Wilde; Jeffrey A Towbin; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Michael J Ackerman; Elizabeth S Kaufman; Nynke Hofman; Rahul Seth; Shiro Kamakura; Yoshihiro Miyamoto; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

9.  Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.

Authors:  Arthur A M Wilde; Arthur J Moss; Elizabeth S Kaufman; Wataru Shimizu; Derick R Peterson; Jesaia Benhorin; Coeli Lopes; Jeffrey A Towbin; Carla Spazzolini; Lia Crotti; Wojciech Zareba; Ilan Goldenberg; Jørgen K Kanters; Jennifer L Robinson; Ming Qi; Nynke Hofman; David J Tester; Connie R Bezzina; Marielle Alders; Takeshi Aiba; Shiro Kamakura; Yoshihiro Miyamoto; Mark L Andrews; Scott McNitt; Bronislava Polonsky; Peter J Schwartz; Michael J Ackerman
Journal:  Circulation       Date:  2016-08-26       Impact factor: 29.690

Review 10.  Congenital long-QT syndromes: a clinical and genetic update from infancy through adulthood.

Authors:  Gregory Webster; Charles I Berul
Journal:  Trends Cardiovasc Med       Date:  2008-08       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.